Northwire Canada EditionWednesday, July 29, 2026
Northwire
NAM 0.250 +0.0% CRD 0.065 +8.3% OLA 12.90 −3.7% CG 22.70 −2.5% EQX 12.89 −4.0% FM 37.51 −2.3% MNRG 0.080 −11.1% KFR 1.31 +0.8% AUMN 0.275 +0.0% GLB 0.250 +0.0% BHS 0.045 −10.0% EGR 0.025 +0.0% RIO 2.59 −4.1% GEN 0.070 +0.0% MAI 4.39 −2.0% RYR 0.175 +0.0% NAM 0.250 +0.0% CRD 0.065 +8.3% OLA 12.90 −3.7% CG 22.70 −2.5% EQX 12.89 −4.0% FM 37.51 −2.3% MNRG 0.080 −11.1% KFR 1.31 +0.8% AUMN 0.275 +0.0% GLB 0.250 +0.0% BHS 0.045 −10.0% EGR 0.025 +0.0% RIO 2.59 −4.1% GEN 0.070 +0.0% MAI 4.39 −2.0% RYR 0.175 +0.0%

← Back to our analysis

Original News Release

Ovation Science arranges $200,000 private placement

An anonymous director reports OVATION SCIENCE INC. ANNOUNCES PRIVATE PLACEMENT Ovation Science Inc. has arranged a non-brokered private placement financing of up to four million units at a price of five cents per unit for total proceeds of up to $200,000. Under the offering, each unit will consist of one common share and one share purchase warrant. Each warrant will entitle the holder to purchase an additional share at a price of five cents per share for a period of 24 months from the date of issue. The units issued under the offering will be subject to a statutory hold period of four months and one day from the date of issuance. In connection with the offering, the company will pay eligible finders a fee in cash equal to 8 per cent of the gross proceeds raised from persons introduced by the finder and/or share purchase warrants equal to 8 per cent of the total number of units subscribed for by persons introduced by the finder. The broker's warrants will be exercisable to purchase an additional share at five cents per share for a period of 24 months from the date of issue. The proceeds of the offering will be used to advance the business of the company and for general working capital. About Ovation Science Inc. Ovation Science is a research and development company that develops topical and transdermal consumer products, including its CBD/THC (cannabidiol/tetrahydrocannabinol) and other cannabinoid formulations, which are licensed out and also distributed under Ovation's own brands, Arlo CBD Beauty and InVibe MD (health and wellness line), all made with its patented Invisicare skin delivery technology. The Invisicare technology enhances the delivery of ingredients to and through the skin, and is protected by patents and proprietary formulations that cannot be duplicated. With over 20 years of topical and transdermal drug delivery experience in the pharmaceutical market, Ovation's management and science teams have created a unique pipeline of over 30 proprietary medical/wellness topical and transdermal products, along with a line of anti-aging/beauty formulas. Ovation earns revenues from royalties on licensees' sales and the sale of Invisicare, along with revenue from its own product sales. Ovation has offices in Vancouver, B.C., Canada, and Las Vegas, Nev., U.S. We seek Safe Harbor.
View at source ↗